Virtual AAHFN Heart Failure Device Summit

Opening Remarks

Start Of Day, Opening Remarks, and Keynote

Keynote: Drugs to Devices: Current Evidence for Heart Failure Management

Objectives

• Describe the universal definition and classification of heart failure

Fundamentals of Pacing

Objectives

• Indications for pacing
• Pacing mode

Why CRT Works, When CRT Works. How to Make CRT Work for Your HF Patient?

Objectives

• The attendee should be able to explain the anatomic targets and physiologic mechanisms of remodeling associated with cardiac resynchronization therapy vs GDMT and recall current indications for CRT (D and P) to identify appropriate candidates in the HF clinic and refer to electrophysiology
• The attendee should be able to identify expected indicators of optimal cardiac resynchronization therapy including: 12-lead EKG findings, patient symptoms and clinical presentation, and device interrogation data in order to achieve beneficial outcomes in HF patients

Cardiac Contractility Modulation: Optimizing Medical Therapy” in the Form of a Device?

Objectives

• To understand the target population for CCM, and the principles of therapy
• To provide insight into the path from patient identification to device implant

Implantable Cardiac Defibrillators: Indications, Clinical Trials and Preventing Shocks

Objectives

• Discuss indications and clinical trial evidence supporting implantable cardiac defibrillator device therapy (subcutaneous and transvenous)
• Review device programming strategies to decrease ICD shocks and promote pain-free therapy

New Strategies for Physiologic Pacing

Objectives

• Describe techniques and rationale for new pacing strategies (HIS bundle and LB pacing) and device implant
• Discuss clinical trial evidence for alternative pacing strategies
• Describe the nurse’s role in patient management pre/post device implant

Baroreceptor Activation Therapy

Objectives

• At the end of this session, learners will be able to identify patients that are appropriate for the Barostim implant.
• At the end of this session, learners will be able to list 2 positive outcomes from the Barostim implant.

Troubleshooting CRT Non-Response

Objectives

• Identify the appropriate patients for biventricular pacing, both before and after BiV device implantation
• Interpret the paced QRS complex to determine if biventricular pacing appears optimal

The Chicken or the Egg: The Reciprocal Relationship Between Sleep Apnea and Heart Failure

Objectives

• The attendee should be able to explain the physiologic causes and differences between central and obstructive sleep apnea, as well as the prevalence of this disease process in HF patients, in order to appreciate the significance of each form as it applies to the etiology, management, and prognosis of HF in the clinical setting
• The attendee should gain a basic understanding of available screening and treatments for central and obstructive sleep apnea, including novel technologies for each, allowing them to assess their patients’ risk, recommend appropriate screening, and inform them of potential treatment options in order to improve outcomes for the HF patient.

ICD and Pacemaker Terminology: What You Need to Know in the HF Clinic

Objectives

• The attendee should be able to recall key device programming and reporting terms associated with the concepts of programming modes, rate response, delays, refractoriness and blanking, and use this knowledge to inform critical review of device interrogation reports in the clinic setting in order to immediately address factors which could negatively impact the HF patient or prompt referral to electrophysiology if appropriate
• The attendee should be able to recall key device programming and reporting terms associated with both ventricular and supraventricular arrhythmia detection and treatment, and use this knowledge to inform critical review of device interrogation reports in the clinic setting in order to immediately address factors which could negatively impact the HF patient or prompt referral to electrophysiology if appropriate

Medtronic Industry Presentation: HF Risk Stratification for Device Patients: Reaching More Patients with Less Resources

Zoll Industry Presentation

Impulse Dynamics Industry Presentation: Sharing my Experience with CCM® Therapy: Case Studies